PDMSA: A Web‐Based Tool for Pan‐Cancer Survival Analysis Using DNA Methylation Levels as Biomarkers
Advanced Genetics · 2026-03 · 7 (1)
DOI: 10.1002/ggn2.202500069 ↗Kurz gefasst
Kommentar in der Zeitschrift Advanced Genetics, online erschienen am 14.03.2026. Verfasst von Weiwei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Zhujiang Hospital The First School of Clinical Medicine Southern Medical University Guangzhou China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA methylation levels are intimately associated with tumor development, progression, and therapeutic outcomes. Accurate analysis of the relationship between DNA methylation levels and tumor prognosis facilitates comprehensive investigation of tumor development mechanisms, enabling optimization of clinical decision‐making and subsequent enhancement of cancer patient survival rates. However, current web‐based tools for analyzing tumor methylation levels and survival prognosis exhibit significant limitations. We have developed a web‐based tool called Pan‐cancer DNA Methylation Survival Analysis (PDMSA) implemented in Shiny, which integrates DNA methylation data and clinical information from large public databases (TCGA and GEO). PDMSA currently encompasses tumor DNA methylation data from 30 TCGA datasets and 15 GEO datasets, consisting of 16 205 211 records that span 39 cancer types, 45 datasets, 19 909 genes, and 8369 samples. The tool executes prognostic Kaplan–Meier survival analysis and Cox regression analysis utilizing two distinct cutoff value grouping methods, offering customizable visualization options for the results. As a user‐friendly analytical platform, PDMSA serves as a comprehensive tool for biomedical researchers to investigate the relationship between methylation levels at specific gene loci and tumor survival outcomes, thereby facilitating the advancement of precision medicine in oncology. Access PDMSA at robinl‐lab.com/PDMSA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology Zhujiang Hospital The First School of Clinical Medicine Southern Medical University Guangzhou China.
- Department of Oncology Zhujiang Hospital Southern Medical University Guangzhou China.
- Department of Microbiology State Key Laboratory of Emerging Infectious Diseases Carol Yu Centre For Infection School of Clinical Medicine Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China.
ORCID-Profile: Peng Luo
Zitieren
APA
Guo, W., Shi, Y., Wu, S., Yang, H., Lin, A., & Luo, P. (2026). PDMSA: A Web‐Based Tool for Pan‐Cancer Survival Analysis Using DNA Methylation Levels as Biomarkers. Advanced Genetics, 7(1). https://doi.org/10.1002/ggn2.202500069
Vancouver
Guo W, Shi Y, Wu S, Yang H, Lin A, Luo P. PDMSA: A Web‐Based Tool for Pan‐Cancer Survival Analysis Using DNA Methylation Levels as Biomarkers. Advanced Genetics. 2026;7(1). doi:10.1002/ggn2.202500069
BibTeX
@article{Guo2026,
author = {Guo, Weiwei and Shi, Ying and Wu, Shanshan and Yang, Hong and Lin, Anqi and Luo, Peng},
title = {PDMSA: A Web‐Based Tool for Pan‐Cancer Survival Analysis Using DNA Methylation Levels as Biomarkers},
journal = {Advanced Genetics},
year = {2026},
volume = {7},
number = {1},
doi = {10.1002/ggn2.202500069}
}
EUVIMED